UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-QSB
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended June 30, 2005
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT
For the transition period from ________ to __________
Commission File Number: 0-27845
TRANSAX INTERNATIONAL LIMITED
-----------------------------
(Exact name of small business issuer as specified in charter)
COLORADO 84-1304106
-------- ----------
(State or other jurisdiction of (I.R.S. Employer I.D. No.)
incorporation or organization)
8th Floor, 5201 Blue Lagoon Drive
Miami, FL, 33126
---------------------------------
(Address of principal executive offices)(Zip Code)
(305) 629-3090
--------------
(Issuer's telephone number, including area code)
Check whether the Issuer (1) has filed all reports required to be filed by
section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes[X] No[ ]
State the number of shares outstanding of each of the Issuer's classes of common
equity as of the latest practicable date: At August 12, 2005, there were
30,322,981 shares of the small business issuer's common stock outstanding.
TRANSAX INTERNATIONAL LIMITED
FORM 10-QSB
QUARTERLY PERIOD ENDED JUNE 30, 2005
INDEX
Page
PART I - FINANCIAL INFORMATION
Item 1 - Consolidated Financial Statements
Consolidated Balance Sheet (Unaudited)
As of June 30, 2005........................................... 3
Consolidated Statements of Operations (Unaudited)
For the Three and Six Months Ended June 30, 2005 and 2004 .... 4
Consolidated Statements of Cash Flows (Unaudited)
For the Six Months Ended June 30, 2005 and 2004............... 5
Notes to Unaudited Consolidated Financial Statements............. 6-16
Item 2 - Management's Discussion and Analysis or Plan of
Operation............................................... 17-22
Item 3 - Controls and Procedures................................. 23
PART II - OTHER INFORMATION
Item 1 - Legal Proceedings....................................... 23
Item 2 - Unregistered Sales of Equity Securities and
Use of Proceeds......................................... 24
Item 3 - Default Upon Senior Securities.......................... 24
Item 4 - Submission of Matters to a Vote of Security Holders..... 24
Item 5 - Other Information....................................... 24
Item 6 - Exhibits................................................ 24
Signatures....................................................... 24
-2-
TRANSAX INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
June 30, 2005
(Unaudited)
ASSETS
CURRENT ASSETS:
Cash ........................................................... $ 64,221
Accounts receivable (Net of allowance for doubtful accounts
of $0) ....................................................... 369,726
Prepaid expenses and other current assets ...................... 100,578
-----------
TOTAL CURRENT ASSETS ........................................ 534,525
SOFTWARE DEVELOPMENT COSTS, net .................................. 279,878
PROPERTY AND EQUIPMENT, net ...................................... 720,758
DEFERRED DEBT OFFERING COSTS ..................................... 200,000
OTHER ASSETS ..................................................... 2,400
-----------
TOTAL ASSETS ................................................ $ 1,737,561
===========
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Current portion of capital lease obligation .................... $ 71,051
Current portion of loan payable ................................ 202,893
Accounts payable and accrued expenses .......................... 1,469,994
Due to related parties ......................................... 172,400
Loan payable - related party ................................... 142,071
Convertible loans from related party ........................... 274,836
-----------
TOTAL CURRENT LIABILITIES ................................... 2,333,245
LOAN PAYABLE ..................................................... 255,237
DEBENTURE PAYABLE, NET ........................................... 216,521
ACCOUNTS PAYABLE AND ACCRUED EXPENSES, net of current portion .... 404,115
-----------
TOTAL LIABILITIES ........................................... 3,209,118
-----------
STOCKHOLDERS' DEFICIT:
Preferred stock $.0001 par value; 20,000,000 shares authorized;
No shares issued and outstanding ............................. -
Common stock $.00001 par value; 100,000,000 shares authorized;
30,122,981 shares issued and outstanding ..................... 300
Paid-in capital ................................................ 7,352,788
Accumulated deficit ............................................ (8,761,242)
Deferred compensation .......................................... (9,625)
Other comprehensive loss - Cumulative foreign currency
adjustment ................................................... (53,778)
-----------
TOTAL STOCKHOLDERS' DEFICIT ................................. (1,471,557)
-----------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT ................. $ 1,737,561
===========
The accompanying notes are an integral part of these
consolidated financial statements.
-3-
TRANSAX INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
FOR THE THREE MONTHS FOR THE SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
2005 2004 2005 2004
------------ ------------ ------------ ------------
REVENUES ....................................... $ 861,023 $ 312,615 $ 1,501,431 $ 450,199
------------ ------------ ------------ ------------
OPERATING EXPENSES:
Cost of product support services ............. 394,533 161,999 596,996 246,849
Payroll and related benefits ................. 103,073 83,271 207,100 165,213
Research & development costs ................. 50,690 28,616 90,022 47,981
Professional fees ............................ 58,980 (64,058) 71,145 33,581
Management & consulting fees - related parties 41,250 78,900 74,965 157,800
Stock based compensation ..................... 26,500 - 80,042 -
Investor relations ........................... 790 2,827 15,635 19,637
Depreciation and amortization ................ 59,027 16,754 103,604 34,751
General & administrative ..................... 181,944 83,015 356,814 184,766
------------ ------------ ------------ ------------
TOTAL OPERATING EXPENSES .................. 916,787 391,324 1,596,323 890,578
------------ ------------ ------------ ------------
LOSS FROM OPERATIONS ........................... (55,764) (78,709) (94,892) (440,379)
------------ ------------ ------------ ------------
OTHER INCOME (EXPENSES):
Other income (expense) ....................... - (11,372) 10,514 (19,203)
Foreign exchange gains (losses) .............. 23,932 18,191 26,434 881
Interest expense ............................. (106,867) (17,514) (167,085) (42,651)
Interest expense - related party ............. (43,788) (22,810) (56,277) (43,032)
------------ ------------ ------------ ------------
TOTAL OTHER EXPENSES ...................... (126,723) (33,505) (186,414) (104,005)
------------ ------------ ------------ ------------
NET LOSS ....................................... (182,487) (112,214) (281,306) (544,384)
OTHER COMPREHENSIVE INCOME:
Unrealized foreign currency translation
gain (loss) ................................. (75,051) 1,496 8,874 19,054
------------ ------------ ------------ ------------
COMPREHENSIVE LOSS ............................. $ (257,538) (110,718) $ (272,432) $ (525,330)
============ ============ ============ ============
NET LOSS PER COMMON SHARE:
BASIC AND DILUTED .............................. $ (0.01) $ (0.01) $ (0.01) $ (0.04)
============ ============ ============ ============
WEIGHTED AVERAGE SHARES OUTSTANDING -
BASIC AND DILUTED ............................ 29,491,294 15,720,910 29,240,092 15,374,472
============ ============ ============ ============
The accompanying notes are an integral part of these
consolidated financial statements.
-4-
TRANSAX INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Six Months
Ended June 30,
---------------------
2005 2004
--------- ---------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss ............................................... $(281,306) $(544,384)
Adjustments to reconcile net loss to net cash
provided by (used in) operating activities:
Depreciation and amortization ..................... 103,604 75,651
Amortization of development costs ................. 66,524 -
Beneficial interest ............................... 93,750 -
Stock-based compensation .......................... 80,041 -
Grant of warrants ................................. 31,200 -
Foreign exchange gain ............................. (18,101) -
Gain on sale of fixed assets ...................... - (251)
Amortization of deferred debt issuance costs ...... 4,783 -
Changes in assets and liabilities:
Accounts receivable ............................... (199,528) (80,114)
Prepaid expenses and other current assets ......... (49,031) (13,899)
Other assets ...................................... (2,400) -
Accounts payable and accrued expenses ............. 379,253 98,250
Accrued interest payable, related party ........... 24,777 43,032
Accrued interest payable .......................... 5,237 7,133
Due to related parties ............................ 1,191 162,316
Accrued payroll and related expenses .............. - 130,660
Other ............................................. - 7,081
Accounts payable and accrued expenses - long-term 11,050 -
--------- ---------
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES .... 251,045 (114,525)
--------- ---------
CASH FLOWS FROM INVESTING ACTIVITIES:
Capitalized software development costs ............... (103,358) (131,212)
Proceeds from disposal of property and equipment ..... - 3,113
Acquisition of property and equipment ................ (381,046) (3,432)
--------- ---------
NET CASH USED IN INVESTING ACTIVITIES .................. (484,404) (131,531)
--------- ---------
CASH FLOWS FROM FINANCING ACTIVITIES:
Advances from related party .......................... - 82,500
Advances from non-related company .................... - 24,000
Repayment of advances from related party ............. (35,000) -
Repayments under capital lease obligations ........... (20,962) (27,131)
Proceeds from convertible debenture .................. 336,738 -
Proceeds from loan payable ........................... 141,982 -
Proceeds from loan - related party ................... - 139,500
Repayment of from loan - related party ............... (15,084) -
--------- ---------
NET CASH PROVIDED BY FINANCING ACTIVITIES .............. 407,674 218,869
--------- ---------
EFFECT OF EXCHANGE RATE CHANGES ON CASH ................ (114,184) 23,096
--------- ---------
NET INCREASE (DECREASE) IN CASH ........................ 60,131 (4,091)
CASH, BEGINNING OF PERIOD .............................. 4,090 10,472
--------- ---------
CASH, END OF PERIOD .................................... $ 64,221 $ 6,381
========= =========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest ............................... $ 15,084 $ 31,564
========= =========
Cash paid for income taxes ........................... $ - $ -
========= =========
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for debt and accrued interest .... $ 137,971 $ 112,500
========= =========
Common stock issued for services ..................... $ 80,041 $ -
========= =========
Grant of common stock warrants in connection debt
conversion .......................................... $ 31,200 $ -
========= =========
The accompanying notes are an integral part of these
consolidated financial statements.
-5-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-QSB and Item 310(b)
of Regulation S-B. Accordingly, the financial statements do not include all of
the information and footnotes required by generally accepted accounting
principles for complete financial statements. In the opinion of management, all
adjustments considered necessary to make the interim financials not misleading
have been included and such adjustments are of a normal recurring nature. These
consolidated financial statements should be read in conjunction with the
financial statements for the year ended December 31, 2004 and notes thereto
contained in the Report on Form 10-KSB of Transax International Limited ("our
Company" or the "Company") as filed with the Securities and Exchange Commission
(the "Commission"). The results of operations for the six months ended June 30,
2005 are not necessarily indicative of the results for the full fiscal year
ending December 31, 2005.
The consolidated financial statements are prepared in accordance with generally
accepted accounting principles in the United States of America ("US GAAP"). The
consolidated financial statements of the Company include the Company and its
subsidiaries. All material intercompany balances and transactions have been
eliminated.
Organization
Transax International Limited was incorporated in the State of Colorado in 1999.
The Company, primarily through its wholly-owned subsidiary TDS Telecommunication
Data Systems Ltda. ("TDS"), is an international provider of information network
solutions specifically designed for healthcare providers and health insurance
companies. The Company's MedLink Solution (TM) enables the real time automation
of routine patient eligibility, verification, authorizations, claims processing
and payment functions. The Company has offices located in Miami, Florida and Rio
de Janeiro, Brazil.
Use of estimates
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the dates of the financial statements and
the reported amounts of revenues and expenses during the reporting periods.
Actual results could differ from those estimates. Estimates used in the
preparation of the accompanying financial statements include the allowance for
doubtful accounts receivable, the useful lives of property, equipment and
software development costs and variables used to determine stock-based
compensation.
Fair Value of Financial Instruments
The fair value of our cash and cash equivalents, accounts receivable, accounts
payable and accrued expenses approximate carrying values due to their short
maturities. The fair values of our debt instruments approximate their carrying
values based on rates currently available to us.
-6-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)
Concentrations of Credit Risk
Financial instruments that potentially subject us to significant concentrations
of credit risk consist principally of cash and accounts receivable.
The Company performs certain credit evaluation procedures and does not require
collateral for financial instruments subject to credit risk. The Company
believes that credit risk is limited because the Company routinely assesses the
financial strength of its customers, and based upon factors surrounding the
credit risk of its customers, establishes an allowance for uncollectible
accounts and, as a consequence, believes that its accounts receivable credit
risk exposure beyond such allowances is limited.
Revenue recognition
Revenue from the sale of software products, which do not require any significant
production, modification or customization for the Company's targeted customers
and do not have multiple elements, is recognized when: (1) persuasive evidence
of an arrangement exists; (2) delivery has occurred; (3) the Company's fee is
fixed and determinable, and; (4) collectibility is probable.
Foreign Currency Translation
The assets and liabilities of the Company's foreign subsidiaries are translated
into U.S. dollars at the year-end exchange rates, equity is converted
historically and all revenue and expenses are translated into U.S. dollars at
the average exchange rates prevailing during the periods in which these items
arise. Translation gains and losses are deferred and accumulated as a component
of other comprehensive income or loss in stockholders' deficit. Transaction
gains and losses that arise from exchange rate fluctuations on transactions
denominated in a currency other than the functional currency (TDS - Brazilian
Real, Transax Australia, - Australian dollar and Transax and the Company - USD)
are included in the Statement of Operations as incurred.
Stock-based compensation
The Company accounts for stock options issued to employees in accordance with
the provisions of Accounting Principles Board ("APB") Opinion No. 25,
"Accounting for Stock Issued to Employees," and related interpretations. As
such, compensation cost is measured on the date of grant as the excess of the
current market price of the underlying stock over the exercise price. Such
compensation amounts are amortized over the respective vesting periods of the
option grant. The Company adopted the disclosure provisions of SFAS No. 123,
"Accounting for Stock-Based Compensation" and SFAS 148, "Accounting for
Stock-Based Compensation -Transition and Disclosure", which permits entities to
provide pro forma net income (loss) and pro forma earnings (loss) per share
disclosures for employee stock option grants as if the fair-valued based method
defined in SFAS No. 123 had been applied. The Company accounts for stock options
and stock issued to non-employees for goods or services in accordance with the
fair value method of SFAS 123.
-7-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)
Stock-based compensation (continued)
The exercise prices of all options granted by the Company exceeded the market
price at the dates of grant. No compensation expense has been recognized. Had
compensation cost for the stock option plan been determined based on the fair
value of the options at the grant dates consistent with the method of SFAS 123,
"Accounting for Stock Based Compensation", the Company's net income and income
per share would have been changed to the pro forma amounts indicated below for
the six months ended June 30, 2005 and 2004:
Six months ended June 30,
-------------------------
2005 2004
--------- ---------
Net loss as reported ...................... $(281,306) $(544,384)
Less: total stock-based employee
compensation expense determined under
fair value based method, net of related tax
effect .................................... (50,871) -
--------- ---------
Pro forma net loss ........................ $(332,177) $(544,384)
========= =========
Basic and diluted loss per share:
As reported ......................... $ (.01) $ (.04)
========= =========
Pro forma ........................... $ (.01) $ (.04)
========= =========
The option grants are estimated as of the date of grant using the Black-Scholes
option-pricing model with the following assumptions used for grants as of June
30, 2005: expected volatility of 205%; risk free interest rate of 3.25%;
expected life of 5 years and annual dividend rate of 0%.
Loss per common share
Basic income (loss) per share is computed by dividing net income (loss) by the
weighted average number of shares of common stock outstanding during the period.
Diluted income per share is computed by dividing net income by the weighted
average number of shares of common stock, common stock equivalents and
potentially dilutive securities outstanding during each period. At June 30,
2005, there were options and warrants to purchase 12,926,070 shares of common
stock, which could potentially dilute future earnings per share, but which are
anti-dilutive for the periods presented above.
Comprehensive Loss
Other comprehensive loss, which currently includes only foreign currency
translation adjustments, is shown in the Statement of Changes in Stockholders'
Deficit.
-8-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)
Recent accounting pronouncements
In December 2004, the FASB issued FASB Statement No. 123R, "Share-Based Payment,
an Amendment of FASB Statement No. 123" ("FAS No. 123R"). FAS No. 123R requires
companies to recognize in the statement of operations the grant- date fair value
of stock options and other equity-based compensation issued to employees. FAS
No. 123R is effective for the first fiscal year beginning after December 15,
2005. The Company is in the process of evaluating the impact of this
pronouncement on its financial position.
In December 2004, the FASB issued SFAS Statement No. 153, "Exchanges of
Non-monetary Assets." The Statement is an amendment to APB Opinion No. 29 which
eliminates the exception for non-monetary exchanges of similar productive assets
and replaces it with a general exception for exchanges of non-monetary assets
that do not have commercial substance. The Company believes that the adoption of
this standard will have no material impact on its financial statements.
In May 2005, FASB issued FASB Statement 154, "Accounting Changes and Error
Corrections -- a replacement of APB Opinion No. 20 and FASB Statement No. 3" ("
FAS 154"). FAS 154 changes the requirements for the accounting for and reporting
of a change in accounting principle. The provisions of FAS 154 require, unless
impracticable, retrospective application to prior periods' financial statements
of (1) all voluntary changes in principles and (2) changes required by a new
accounting pronouncement, if a specific transition is not provided. FAS 154 also
requires that a change in depreciation, amortization, or depletion method for
long-lived, non-financial assets be accounted for as a change in accounting
estimate, which requires prospective application of the new method. FAS 154 is
effective for all accounting changes made in fiscal years beginning after
December 15, 2005.
NOTE 2 - RELATED PARTY TRANSACTIONS
Convertible Loans Payable
At December 31, 2004, the Company had loans payable for $200,000 and $100,000 to
a related party whose officer is an officer of the Company. On March 23, 2005,
the Company modified the terms of its convertible loans to this related party.
Under the modified terms, $200,000 of principal due under the convertible loans
is due on March 31, 2007 and is convertible into the Company's common stock at
$.125 per share. The remaining principal of $100,000 is due on April 30, 2007
and is convertible into the Company's common stock at $.125 per share. For each
common share received upon conversion of the principal balance, the related
party is entitled to receive one warrant to purchase the Company's common stock
at $.25 per share for a period of two years from the conversion date. The
interest rate of the loan is 12% per annum compounded monthly. On June 28, 2005,
the holder of the notes partially exercised the conversion feature. Accordingly,
the Company issued 400,000 shares and 400,000 warrants to purchase common stock
of the Company for the conversion of principal balance of $50,000. The Company
also issued 35,770 shares of common stock to settle $4,471 in interest due on
these loans. At June 30, 2005, interest due on these two loans amounted to
$24,836 and the aggregate principal amount due is $250,000. During the six
months ended June 30, 2005 and 2004, the Company incurred $17,852 and $24,132,
respectively, in interest related to these two loans. The Company did not incur
beneficial conversion charges because the conversion price was equivalent to the
average offering price for equity when these loans became convertible.
-9-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 2 - RELATED PARTY TRANSACTIONS (CONTINUED)
Due to Related Parties
As of June 30, 2005 the Company had $20,905 of advances payable and accrued
interest due to a related party whose officer is an officer of the Company.
For the six months ended June 30, 2005 and 2004, the Company incurred $82,500
and $66,000, respectively, in management fees to an officer/director of the
Company. On January 14, 2005, the board of directors voted to increase the
compensation paid to this officer/director from $11,000 per month to $13,750 per
month, effective January 1, 2005. On March 28, 2005, the Company issued 400,000
shares of common stock at $.126 per share to this officer/director for
settlement of $50,500 of this debt. On June 28, 2005, the Company issued 300,000
shares of common stock at $.11 per share to this officer/director for settlement
of $33,000 of this debt.. The fair market value of these shares were based on
the average price of the Company's shares traded between June 14 and June 27,
2005. At June 30, 2005, $137,343 in management fees and other expenses were
outstanding to this officer/director and are included in due to related parties
on the accompanying balance sheet. The amounts due are unsecured, non-interest
bearing and are payable on demand.
At June 30, 2005, $14,152 in management fees and expenses payable was due to a
director of the Company and is included in due to related parties on the
accompanying balance sheet. The amounts due are unsecured, non-interest bearing
and are payable on demand.
Loan Payable - Related Party
On March 5, 2004, the Company borrowed Euro 115,000 ($138,759 at June 30, 2005)
from an officer of the Company for working capital purposes. The loan accrues
0.8% compounded interest per month, has a term of twelve months, and the debt is
repayable quarterly in arrears. During the six months ended June 30, 2005 and
2004, the Company incurred $7,225 and $3,721, respectively, in interest related
to this loan. As at June 30, 2005, $3,312 in interest was accrued on this loan
and is included in loan payable - related party on the accompanying balance
sheet. The officer agreed to extend the loan for an additional twelve months
until March 2006.
NOTE 3 - FINANCING ARRANGEMENTS
Loan Payable
On October 25, 2004, the Company and Cornell Capital Partners entered into a
Securities Purchase Agreement, pursuant to which Cornell Capital Partners
purchased two 5% secured convertible debentures. The initial convertible
debenture in the original principal amount of $125,000 was dated October 25,
2004 and the second convertible debenture in the original principal amount of
$125,000 was dated January 4, 2005 (collectively, the "Original Debentures"). In
connection with the terms of the original debentures, for the six months ended
June 30, 2005, the Company recorded a beneficial conversion amount of $31,250 as
interest expense since the debentures were immediately convertible. On May 17,
2005, the Company and Cornell Capital Partners entered into a $255,237
Promissory Note (the "Note"), whereby the Original Debentures were terminated.
This Note represents the outstanding principal balance of $250,000 on the
Original Debentures, plus accrued but unpaid interest through April 30, 2005
equal to $5,237. The Note bears interest at a rate of 12% per annum and is
secured by stock pledged by certain shareholders of the Company. As of June 30,
2005, the Company has accrued interest payable of $2,552 related to this Note
which is included in accounts payable and accrued expenses on the accompanying
balance sheet.
-10-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 3 - FINANCING ARRANGEMENTS (CONTINUED)
Debenture Payable
On April 1, 2005, the Company entered into a Securities Purchase Agreement with
Scott and Heather Grimes, Joint Tenants - with Rights of Survivorship (the
"Investor"). Pursuant to the Securities Purchase Agreement, the Company issued
convertible debentures to the Investor in the original principal amount of
$250,000. The debentures are convertible at the holder's option any time up to
maturity at a conversion price equal to the lower of (i) 120% of the closing bid
price of the common stock on the date of the debentures or (ii) 80% of the
lowest closing bid price of the common stock for the five trading days
immediately preceding the conversion date. The debentures have a two-year term
and accrue interest at 5% per year. At maturity, the debentures will
automatically convert into shares of common stock at a conversion price equal to
the lower of (i) 120% of the closing bid price of the common stock on the date
of the debentures or (ii) 80% of the lowest closing bid price of the common
stock for five trading days immediately preceding the conversion date. In April
2005, Company recorded a beneficial conversion amount of $62,500 as interest
expense since the debentures were immediately convertible. Additionally, the
Company paid fees of $38,262 in connection with this debenture. These fees were
treated as a discount on the convertible debenture and are being amortized over
the debenture term. Amortization expense for the six months ended June 30, 2005
was $4,783 and is included in interest expense.
The convertible debenture liability is as follows at June 30, 2005:
Convertible debentures payable .............. $ 250,000
Less: unamortized discount on debentures .... (33,479)
---------
Convertible debentures, net ................. $ 216,521
=========
Standby Equity Distribution Agreement
On October 25, 2004, the Company entered into a Standby Equity Distribution
Agreement with Cornell Capital Partners. Pursuant to the Standby Equity
Distribution Agreement, the Company could, at its discretion, periodically sell
to Cornell Capital Partners shares of common stock for a total purchase price of
up to $5.0 million.
On May 17, 2005, the Company entered into a Termination Agreement with Cornell
Capital Partners, whereby that certain Standby Equity Distribution Agreement,
dated October 25, 2004, and the related Registration Rights Agreement, Placement
Agent Agreement and Escrow Agreement of even date therewith were terminated.
Upon execution of the Termination Agreement, the Company entered into a new
Standby Equity Distribution Agreement with Cornell Capital Partners on May 17,
2005. Pursuant to the Standby Equity Distribution Agreement, the Company may, at
its discretion, periodically sell to Cornell Capital Partners shares of common
stock for a total purchase price of up to $5.0 million. For each share of common
stock purchased under the Standby Equity Distribution Agreement, Cornell Capital
Partners will pay the Company 97% of, or a 3% discount to, the lowest closing
bid price of the Company's common stock on the Over-the-Counter Bulletin Board
or other principal market on which the Company's common stock is traded for the
five days immediately following the notice date. Cornell Capital Partners will
also retain 5% of each advance under the Standby Equity Distribution Agreement.
Cornell Capital Partner's obligation to purchase shares of the Company's common
stock under the Standby Equity Distribution Agreement is subject to certain
conditions, including the Company obtaining an effective registration statement
for shares of common stock sold under the Standby Equity Distribution Agreement
and is limited to $200,000 per weekly advance and $1,000,000 per 30 days.
-11-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 3 - FINANCING ARRANGEMENTS (CONTINUED)
Standby Equity Distribution Agreement (continued)
Under the now-terminated Standby Equity Distribution Agreement (SEDA) originally
dated October 25, 2004 and the terminated compensation debenture in December
2004, Cornell Capital Partners received a one-time commitment fee in the form of
1,201,779 shares of common stock in the amount of $200,000. In December 2004,
the Company valued the common shares issued to Cornell at the fair market value
on the dates of grant or $0.1664 per share or $200,000 based on the quoted
trading price for the stock. From December 2004 through May 27, 2005, the
Company renegotiated the terms of the SEDA and the related agreements and did
not amortize the commitment fee. At June 30, 2005, the commitment fee was deemed
to be a deferred debt offering cost on the accompanying balance sheet and will
be amortized as a financing expense over the effective period of 24 months or
less if funded earlier. Since as of June 30, 2005, the Company's registration
was not yet declared effective, the Company did not begin amortizing the
commitment fee.
NOTE 4 - STOCKHOLDERS' DEFICIT
Common Stock
On January 14, 2005, the Company entered into a six-month consulting contract
for business development services. In connection with the agreement, the Company
issued 400,000 shares of common stock. On May 10, 2005, the Company cancelled
this contract and cancelled 200,000 shares that were due on this contract. The
Company valued these common shares at the fair market value on the date of grant
of $0.16 based on the quoted trading price and recorded stock-based consulting
expense of $42,667 through the date of cancellation.
On January 14, 2005, the Company entered into a consulting contract for business
development services. In connection with the agreement, the Company issued
100,000 shares of common stock. The Company valued these common shares at the
fair market value on the date of grant of $0.16 based on the quoted trading
price and recorded stock-based compensation expense of $16,000.
On March 21, 2005, the Company entered into a consulting contract for business
development services. In connection with the agreement, the Company issued
150,000 shares of common stock. The Company valued these common shares at the
fair market value on the dates of grant or $0.14 or $21,000 based on the quoted
trading price and recorded stock-based consulting expense of $11,375 and
deferred consulting expense of $9,625 to be amortized over the remaining service
period.
On March 28, 2005, the Company issued 400,000 shares of common stock to settle
$50,500 in debt due to an officer/director of the Company. The Company valued
these common shares at the fair market value on the date of grant of $0.126.
On June 28, 2005, the holder of the related party loans (see note 2) exercised
the conversion feature. Accordingly, the Company issued 400,000 shares and the
conversion price of $.125 per share and 400,000 warrants to purchase common
stock of the Company at $.25 per share (see note 3) for the conversion of
principal balance of $50,000. The Company also issued 35,770 shares of common
stock to settle $4,471 in interest due on these loans.
On June 28, 2005, the Company issued 300,000 shares of common stock at $.11 per
share, the fair market value on the date of grant, to this officer/director for
settlement of $33,000 of this debt.
-12-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 4 - STOCKHOLDERS' DEFICIT (CONTINUED)
Stock Options
On January 14, 2005, the board of directors elected to extend the expiration
date of 373,570 warrants from December 31, 2004 to December 31, 2005.
On November 28, 2004, the Company adopted a 2004 Incentive Stock Option Plan
(the "Plan"). The Plan provides options to be granted, exercisable for a maximum
of 2,500,000 shares of common stock. Both incentive and nonqualified stock
options may be granted under the Plan. The exercise price of options granted,
the expiration date, and the vesting period, pursuant to this plan is determined
by a committee.
On May 5, 2005, the Company granted options to purchase an aggregate of
1,000,000 shares of common stock to employees, officers and directors of the
Company. The options are exercisable at $0.15 per share, which exceeds the fair
market value of the common stock at the grant date. Accordingly, under APB 25,
no compensation expense was recognized. The options expire on May 5, 2010.
A summary of the status of the Company's outstanding stock options as of June
30, 2005 and changes during the period then ended is as follows:
Weighted
Average
Exercise
Shares Price
--------- --------
Outstanding at December 31, 2004 .......... 2,425,000 0.41
Granted .................................. 1,000,000 0.15
Exercised ................................ - -
Forfeited ................................ - -
--------- ------
Outstanding at June 30, 2005 ............. 3,425,000 $ 0.33
========= ======
Options exercisable at end of period ..... 3,425,000 $ 0.33
========= ======
Weighted-average fair value of options
granted during the period ............ 2005
------
$ 0.15
The following information applies to options outstanding at June 30, 2005:
Options Outstanding Options Exercisable
------------------------- ----------------------
Weighted
Average Weighted Weighted
Range of Remaining Average Average
Exercise Contractual Exercise Exercise
Prices Shares Life (Years) Price Shares Price
-------- --------- ------------ -------- --------- --------
$0.50 1,675,000 3.62 $ 0.50 1,675,000 $ 0.50
$0.20 750,000 5.00 $ 0.20 750,000 $ 0.20
$0.15 1,000,000 4.80 $ 0.15 1,000,000 $ 0.15
-13-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 4 - STOCKHOLDERS' DEFICIT (CONTINUED)
Stock Warrants
A summary of the status of the Company's outstanding stock warrants as of June
30, 2005 and 2004 and changes during the period then ended is as follows:
Weighted
Average
Exercise
Shares Price
--------- --------
Outstanding at December 31, 2004 9,101,070 0.61
Granted 400,000 0.25
Exercised - -
Forfeited - -
--------- ------
Outstanding at June 30, 2005 9,501,070 $ 0.60
========= ======
Warrants exercisable at end of period 9,501,070 $ 0.60
========= ======
2005
------
Weighted-average fair value of warrants
granted during the period $ 0.25
The following information applies to all warrants outstanding at June 30, 2005:
Warrants Outstanding Warrants Exercisable
------------------------- ----------------------
Weighted
Average Weighted Weighted
Range of Remaining Average Average
Exercise Contractual Exercise Exercise
Prices Shares Life (Years) Price Shares Price
-------- --------- ------------ -------- --------- --------
$1.00 4,325,000 3.61 $ 1.00 4,325,000 $ 1.00
$0.50 373,570 1.00 $ 0.50 373,570 $ 0.50
$0.30 2,000,000 2.00 $ 0.30 2,000,000 $ 0.30
$0.20 2,402,500 4.75 $ 0.20 2,402,500 $ 0.20
$0.25 400,000 2.00 $ 0.25 400,000 $ 0.25
NOTE 5 - LITIGATION
An action has been brought against the Company by its former stock transfer
agent who alleges, among other items, that the Company breached its contract
with the transfer agent. The Company has filed an answer to the action and a
portion of the action has been dismissed by the court. The Company intends to
vigorously defend itself against the remainder of the action. Counsel has
advised the Company that there is a better than fifty percent chance that a
potential loss will be incurred. Accordingly, as of December 31, 2004, an
accrual of $50,000 was recorded which, as of June 30, 2005, is included in
accounts payable and accrued expenses on the accompanying balance sheet.
-14-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 6 - FOREIGN OPERATIONS
The Company identifies its operating segments based on its business activities
and geographical locations. The Company operates within a single operating
segment, being a provider of information network solutions specifically designed
for healthcare providers and health insurance companies. The Company operates in
Brazil, Australia and Mauritius, and has a registered mailing address in
Singapore and in the USA. All of the Company's assets are located in Brazil.
Six Months Ended Six Months Ended
June 30, June 30,
2005 2004
---------------- ----------------
Net sales to Unaffiliated Customers:
Brazil ............................... $ 1,501,431 $ 450,199
USA .................................. - -
Singapore ............................ - -
Australia ............................ - -
Mauritius ............................ - -
----------- -----------
Total Sales ....................... 1,501,431 450,199
----------- -----------
Operating Expenses:
Brazil ............................... 1,216,321 662,392
USA .................................. 336,595 206,871
Singapore ............................ - -
Australia ............................ 7,176 85
Mauritius ............................ 36,231 21,230
----------- -----------
Total Operating Expenses ............. 1,596,323 890,578
----------- -----------
Loss from operations ................... (94,892) (440,379)
----------- -----------
Other income (expenses):
Brazil ............................... (59,242) (54,722)
USA .................................. (135,122) (49,709)
Australia ............................ 7,950 426
----------- -----------
(186,414) (104,005)
----------- -----------
Net loss as reported in the
accompanying statements ............... $ (281,306) $ (544,384)
=========== ===========
-15-
TRANSAX INTERNATIONAL LIMITED
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2005
NOTE 7 - GOING CONCERN
Since inception, the Company has incurred cumulative net losses of $8,761,242,
has a stockholders' deficit of $1,471,557 at June 30, 2005 and has a working
capital deficit of $1,798,720. Since its inception, the Company has funded
operations through short-term borrowings and equity investments in order to meet
its strategic objectives. The Company's future operations are dependent upon
external funding and its ability to increase revenues and reduce expenses.
Management believes that sufficient funding will be available from additional
related party borrowings and private placements to meet its business objectives,
including anticipated cash needs for working capital, for a reasonable period of
time. Additionally, under the current roll out schedules with its clients, the
Company expects to increase its revenues significantly during 2005 with the
expectation of the Company becoming a profitable entity. However, there can be
no assurance that the Company will be able to obtain sufficient funds to
continue the development of its software products and distribution networks.
Further, since fiscal 2000, the Company has been deficient in the payment of
Brazilian payroll taxes and Social Security taxes. At June 30, 2005, these
deficiencies (including interest and fines) amounted to approximately $762,000.
This payroll liability is included as part of the accounts payable and accrued
expenses (short-term and long-term) within the consolidated balance sheet.
As a result of the foregoing, there exists substantial doubt about the Company's
ability to continue as a going concern. These consolidated financial statements
do not include any adjustments that might result from the outcome of this
uncertainty.
NOTE 8 - SUBSEQUENT EVENTS
On July 15, 2005, the Company entered into a one-year consulting contract for
public relations services. For services rendered, the Company shall pay $5,000
per month payable in cash and/or free-trading common stock. In connection with
this agreement, the Company issued 200,000 shares of common stock. The Company
valued these common shares at the fair market value on the dates of grant of
$0.15 per share or $30,000 based on the quoted trading price and recorded
deferred consulting expense of $30,000 to be amortized over the service period.
-16-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
This report on Form 10-QSB contains forward-looking statements that are subject
to risks and uncertainties that could cause actual results to differ materially
from those discussed in the forward-looking statements and from historical
results of operations. Among the risks and uncertainties which could cause such
a difference are those relating to our dependence upon certain key personnel,
our ability to manage our growth, our success in implementing the business
strategy, our success in arranging financing where required, and the risk of
economic and market factors affecting us or our customers. Many of such risk
factors are beyond the control of the Company and its management.
GENERAL
Transax International Limited, a Colorado corporation (the "Company"), currently
trades on the OTC Bulletin Board under the symbol "TNSX"". Transax International
Limited is referred to in this Form 10-QSB as "we".
Through our wholly-owned subsidiary TDS Telecommunication Data Systems LTDA
("TDS"), we are an international provider of health information management
products (collectively, the "Health Information Management Products"), which are
specifically designed for the healthcare providers and health insurance
companies. We are dedicated to improving healthcare delivery by providing to
hospitals, physician practices and health insurance companies with innovative
health information management systems to manage coding, compliance, abstracting
and record management processes. We have developed a proprietary software
trademarked (Brazil only) "MedLink Solution", which was specifically designed
and developed for the healthcare and health insurance industry enabling the real
time automation of routine patient eligibility, verifications, authorizations,
claims processing and payment functions that are currently performed manually
(the "MedLink Solution").
RESULTS OF OPERATIONS
SIX-MONTH PERIOD ENDED JUNE 30, 2005 COMPARED TO SIX-MONTH PERIOD ENDED JUNE 30,
2004
Our net losses during the six-month period ended June 30, 2005 were $281,306
compared to a net loss of $544,384 during the six-month period ended June 30,
2004. During the six month period ended June 30, 2005, we generated $1,501,431
in net revenues compared to $450,199 in net revenues for the six months ended
June 30, 2004, an increase of $1,051,232 or 233.5%. The significant increase in
revenues is due to the continued rollout of software contracts in Brazil. We
undertook approximately 3.0 million "real-time" transactions during the first
and second quarter of 2005 compared to 1.1 million "real-time" transactions
during the same period in 2004. We installed a record 1043 Point of Sales (POS)
solutions during the six months ended June 30, 2005. At the end of June 2005 we
had 4,600 solutions operational in Brazil including 2345 Point of Sales
solutions.
-17-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (CONTINUED)
SIX-MONTH PERIOD ENDED JUNE 30, 2005 COMPARED TO SIX-MONTH PERIOD ENDED JUNE 30,
2004
During the six-month period ended June 30, 2005, we incurred operating expenses
of $1,596,323 compared to operating expenses of $890,578 incurred during the
six-month period ended June 30, 2004, an increase of $705,745 or 79.3%. The
increase in operating expenses during the six-month period ended June 30, 2005
from the same period in 2004 resulted from: (i) an increase of $350,147, or
approximately 141.8%, in cost of product support services resulting from the
increase in net revenues; (ii) an increase of $41,887, or approximately 25.3%,
in payroll and related benefits due to an increase in employees needed to handle
our increased operations; (iii) an increase of $172,048, or 93%, in general and
administrative expenses resulting from increased operating costs associated with
increased operations; (iv) an increase of $80,042, or 100%, in stock-based
compensation and consulting fees as a result of an increase in stock issuances
to employees, officers and consultants; (v) an increase of $68,853, or
approximately 198%, in depreciation and amortization expense as a result of an
increase in property and equipment acquired for our TDS operations, (vi) an
increase in research and development costs of $42,041 related to increased
amortization of development costs associated with our software, and (vii) an
increase in professional fees of $37,564 related to our SEC filings and filing
of a registration statement of form SB-2.
Certain operating expenses, however, decreased during the six-month period ended
June 30, 2005 from the same period in 2004 as follows: (i) a decrease of
$82,835, or 52.5%, in management and consulting fees, which is attributable to a
decrease in the use of consultants; and (ii) a decrease of $4,002, or
approximately, 20.4%, in investor relation fees attributable to a decrease in
the use of investor relations services.
We reported a loss from operations of ($94,892) for the six-month period ended
June 30, 2005 as compared to a loss from operations of ($440,379) for the
six-month period ended June 30, 2004. Although there can be no assurances, we
anticipate that during the fiscal year 2005, our ongoing marketing efforts and
product roll-out will result in an increase in our net sales from those reported
in the six months ended June 30, 2005. To support these increased sales, we
anticipate that our operating expenses will also increase during the fiscal year
2005 as compared to the fiscal 2004. We are, however, unable to predict at this
time the amount of any such increase in operating expenses.
Total other expenses increased $82,409, or approximately 79.2%, for six months
ended June 30, 2005 as compared to the six months ended June 30, 2004. Included
in this change is: (i) an increase in other income of $29,717 due to the income
recognized upon settlement of accounts payable balances which were settled for
less than the original obligation.; (ii) an increase of $137,679 or
approximately 160.7%, in interest expense for the six months ended June 30, 2005
as compared to the six months ended June 30, 2004 which reflects an increase in
our borrowings during six months ended June 30, 2005, the recording of
beneficial interest of $62,500 and interest expense recorded in connection with
the grant of warrants upon debt conversion of $31,200; and (iii) an increase of
$25,553 in foreign exchange rate gains due to a favorable fluctuation in the
exchange rate between Brazil and the United States..
For the six months ended June 30, 2005, our net loss was ($281,306) or ($0.01)
per common share compared to a net loss of ($544,384) or ($0.04) per common
share for the six month period ended June 30, 2004.
-18-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (CONTINUED)
THREE-MONTH PERIOD ENDED JUNE 30, 2005 COMPARED TO THREE-MONTH PERIOD ENDED JUNE
30, 2004
Our net losses during the three-month period ended June 30, 2005 were $182,487
compared to a net loss of $112,214 during the three-month period ended June 30,
2004. During the three-month period ended June 30, 2005, we generated $861,023
in net revenues compared to $312,615 in net revenues for the three-months ended
June 30, 2004, an increase of $548,408 or 175.4%. The significant increase in
revenues is due to the continued rollout of software contracts in Brazil as
discussed above.
During the three-month period ended June 30, 2005, we incurred operating
expenses of $916,787 compared to operating expenses of $391,324 incurred during
the three-month period ended June 30, 2004, an increase of $525,463 or 134.3%.
The increase in operating expenses during the three-month period ended June 30,
2005 from the same period in 2004 resulted from: (i) an increase of $232,534, or
approximately 143.5%, in cost of product support services resulting from the
increase in net revenues; (ii) an increase of $19,802, or approximately 23.8%,
in payroll and related benefits due to an increase in employees needed to handle
our increased operations; (iii) an increase of $98,929, or 119.2%, in general
and administrative expenses resulting from increased operating costs associated
with increased operations; (iv) an increase of $26,500, or 100%, in stock-based
compensation and consulting fees as a result of an increase in stock issuances
to employees, officers and consultants; (v) an increase of $42,273, or
approximately 252.3%, in depreciation and amortization expense as a result of an
increase in property and equipment acquired for our TDS operations, (vi) an
increase in research and development costs of $22,074 related to increased
amortization of development costs associated with our software, and (vii) an
increase in professional fees of $123,038 related to our SEC filings and the
filing of a registration statement, Form SB-2.
Certain operating expenses, however, decreased during the three-month period
ended June 30, 2005 from the same period in 2004 as follows: (i) a decrease of
$37,650, or 47.7%, in management and consulting fees, which is attributable to a
decrease in the use of consultants; and (ii) a decrease of $2,037, or
approximately, 72.1%, in investor relation fees attributable to a decrease in
the use of investor relations services.
We reported a loss from operations of ($55,764) for the three-month period ended
June 30, 2005 as compared to a loss from operations of ($78,709) for the
three-month period ended June 30, 2004.
Total other expenses increased $93,218, or approximately 278.2%, for three
months ended June 30, 2005 as compared to three months ended June 30, 2004.
Included in this change is: (i) a decrease in other expense of $11,372 as
reported for the three months ended June 30, 2004.; (ii) an increase of
$110,331, or approximately 273.6%, in interest expense for the three months
ended June 30, 2005 as compared to the three months ended June 30, 2004; and
(iii) an increase of $5,741 in foreign exchange rate gains due to a favorable
fluctuation in exchange rate between Brazil and the United States..
Therefore, our net loss during the three month period ended June 30, 2005 was
($182,487) or ($0.01) per common share compared to a net loss of ($112,214) or
($0.01) per common share for the three month period ended June 30, 2004.
LIQUIDITY AND CAPITAL RESOURCES
As of June 30, 2005, our current assets were $534,525 and our current
liabilities were $2,333,244, which resulted in a working capital deficit of
$1,798,719. As of June 30, 2005, our total assets were $1,737,561 consisting of:
(i) $64,221 in cash; (ii) $100,578 in prepaid expenses and other assets; (iii)
$369,726 in accounts receivable; (iv) 279,878 in net software development costs;
(v) $720,758 in net valuation of property and equipment; and (vi) deferred debt
offering costs of $200,000 which will be amortized into interest expense over
time.
As of June 30, 2005, our total liabilities were $3,209,117 consisting of: (i)
$1,874,109 in long-term and current portion of accounts payable and accrued
expenses; (ii) $172,400 due to related parties; (iii) $274,836 in convertible
loans to related parties; (iv) $142,071 in loan payable to related parties; (v)
$71,051 in long-term and current portion of capital lease obligation; (vi)
$216,521 in convertible debenture payable; and (ix) $458,130 in long-term and
current portion of loan payable.
-19-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (CONTINUED)
As at June 30, 2005, our current liabilities were $2,333,244 compared to
$2,121,551 at December 31, 2004. The increase in current liabilities is due
primarily to an increase in accounts payable and accrued expenses and additional
loans to fund operations.
For the six months ended June 30, 2005, net cash flow provided by operating
activities was $251,045 compared to net cash used in operating activities of
$114,525 for the six months ended June 30, 2004. The change in cash flows used
in operating activities is mainly due to the decrease in operating loss for the
period.
Net cash flows used in investing activities amounted to $484,404 for the six
months ended June 30, 2005 compared to $131,531 for the six months ended June
30, 2004, an increase in cash used in investing activities of $352,873. The
increase is primarily attributable to an increase in the acquisition of property
and equipment in order to facilitate our growth in revenues.
Net cash flow provided by financing activities for the six months ended June 30,
2005 was $407,674 resulting primarily from proceeds from a convertible debenture
and loans payable compared to $218,869 for the six months ended June 30, 2004
resulting from proceeds from related party loans of $139,500 and advanced from
related parties of $82,500.
In summary, based upon the cash flow activities as previously discussed, for the
six months ended June 30, 2005, our overall cash position increased by $60,131.
PLAN OF OPERATION
Since our inception, we have funded operations through short-term borrowings and
equity investments in order to meet our strategic objectives. Our future
operations are dependent upon external funding and our ability to increase
revenues and reduce expenses. Management believes that sufficient funding will
be available from additional related party borrowings and private placements to
meet our business objectives including anticipated cash needs for working
capital, for a reasonable period of time. However, there can be no assurance
that we will be able to obtain sufficient funds to continue the development of
our software products and distribution networks.
As of the date of this quarterly report, there is substantial doubt regarding
our ability to continue as a going concern as we have not generated sufficient
cash flow to fund our business operations and material commitments. Our future
success and viability, therefore, are dependent upon our ability to develop,
provide and market our information network solutions to healthcare providers,
health insurance companies and other end-users, and the continuing ability to
generate capital financing. We are optimistic that we will be successful in our
business operations and capital raising efforts; however, there can be no
assurance that we will be successful in generating revenue or raising additional
capital. The failure to generate sufficient revenues or raise additional capital
may have a material and adverse effect upon us and our shareholders.
We anticipate an increase in operating expenses over the next three years to pay
costs associated with such business operations. We may need to raise additional
funds. We may finance these expenses with further issuances of our common stock.
We believe that any anticipated private placements of equity capital and debt
financing, if successful, may be adequate to fund our operations over the next
twelve months. Thereafter, we expect we will need to raise additional capital to
meet long-term operating requirements. If we raise additional funds through the
issuance of equity or convertible debt securities other than to current
shareholders, the percentage ownership of our current shareholders would be
reduced, and such securities might have rights, preferences or privileges senior
to our existing common stock. In addition, additional financing may not be
available upon acceptable terms, or at all. If adequate funds are not available,
or are not available with acceptable terms, we may not be able to conduct our
business operations successfully, which could significantly and materially
restrict our overall business operations.
-20-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (CONTINUED)
Based upon a twelve-month work plan proposed by management, it is anticipated
that such a work plan would require approximately $2,000,000 to $5,000,000 of
financing designed to fund current debt commitments and business operations. As
of the date of this quarterly report, we entered into a financing agreement with
Scott and Heather Grimes, Joint Tenants with Right of Survivorship (the
"Investor"). Under the terms of the financing arrangement with the Investor, we
issued convertible debentures to the Investor in the original principal amount
of $250,000. The debentures are convertible at the Investor's option any time up
to maturity at a conversion price equal to the lower of: (i) 120% of the closing
bid price of our Common Stock on the date of the debentures, or (ii) 80% of the
lowest closing bid price of our Common Stock for the five trading days
immediately preceding the conversion date. The debentures have a two-year term
and accrue interest at 5% per year. At maturity, the debentures will
automatically convert into shares of our Common Stock at a conversion price
equal to the lower of: (i) 120% of the closing bid price of our Common Stock on
the date of the debentures, or (ii) 80% of the lowest closing bid price on our
Common Stock for five trading days immediately preceding the conversion date.
Additionally, we entered into a new Standby Equity Distribution Agreement with
Cornell Capital Partners on May 17, 2005. Pursuant to the Standby Equity
Distribution Agreement, we may, at our discretion, periodically sell to Cornell
Capital Partners shares of common stock for a total purchase price of up to $5.0
million.
We believe that we can satisfy our cash requirements for the next twelve months
based on our ability to enter into additional financing arrangement as
necessary. Our future success and viability are primarily dependent upon our
current management to generate revenues from business operations and raise
additional capital through further private offerings of our stock or loans from
private investors. There can be no assurance, however, that we will be able to
raise additional capital. Our failure to successfully raise additional capital
will have a material and adverse affect upon us and our shareholders.
OFF BALANCE SHEET ARRANGEMENTS
As of the date of this quarterly report, we do not have any off-balance sheet
arrangements that have or are reasonably likely to have a current or future
effect on our financial condition, changes in financial condition, revenues or
expenses, results of operations, liquidity, capital expenditures or capital
resources that are material to investors. The term "off-balance sheet
arrangement" generally means any transaction, agreement or other contractual
arrangement to which an entity unconsolidated with us is a party, under which we
have: (i) any obligation arising under a guarantee contract, derivative
instrument or variable interest; or (ii) a retained or contingent interest in
assets transferred to such entity or similar arrangement that serves as credit,
liquidity or market risk support for such assets.
CRITICAL ACCOUNTING POLICIES
Our financial statements and accompanying notes are prepared in accordance with
generally accepted accounting principles in the United States. Preparing
financial statements requires management to make estimates and assumptions that
affect the reported amounts of assets, liabilities, revenue and expenses. These
estimates and assumptions are affected by management's applications of
accounting policies. Critical accounting policies for Transax International
Limited includes the useful live of property and equipment and accounting for
stock based compensation.
Under the criteria set forth in SFAS No. 86, "Accounting for the Costs of
Computer Software to be Sold, Leased or Otherwise Marketed," capitalization of
software development costs begins upon the establishment of technological
feasibility of the software. The establishment of technological feasibility and
the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but
not limited to, anticipated future gross product revenues, estimated economic
life, and changes in software and hardware technology. Capitalized software
development costs are amortized utilizing the straight-line method over the
estimated economic life of the software not to exceed three years. We regularly
review the carrying value of software development assets and a loss is
recognized when the unamortized costs are deemed unrecoverable based on the
estimated cash flows to be generated from the applicable software.
-21-
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION (CONTINUED)
We review the carrying value of property and equipment for impairment at least
annually or whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable. Recoverability of long-lived
assets is measured by comparison of its carrying amount to the undiscounted cash
flows that the asset or asset group is expected to generate. If such assets are
considered to be impaired, the impairment to be recognized is measured by the
amount by which the carrying amount of the property, if any, exceeds its fair
market value.
Accounting for Stock Based Compensation - We account for stock options issued to
employees in accordance with the provisions of Accounting Principles Board
("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and related
interpretations. As such, compensation cost is measured on the date of grant as
the excess of the current market price of the underlying stock over the exercise
price. Such compensation amounts are amortized over the respective vesting
periods of the option grant. The Company adopted the disclosure provisions of
SFAS No. 123, "Accounting for Stock-Based Compensation" and SFAS 148,
"Accounting for Stock-Based Compensation -Transition and Disclosure", which
permits entities to provide pro forma net income (loss) and pro forma earnings
(loss) per share disclosures for employee stock option grants as if the
fair-valued based method defined in SFAS No. 123 had been applied. The Company
accounts for stock options and stock issued to non-employees for goods or
services in accordance with the fair value method of SFAS 123. We are required
to comply with SFAS No. 123 (revised 2004) starting on the first day of our
fiscal year 2006. We are currently evaluating the effect that the adoption of
SFAS No. 123 (revised 2004) will have on our consolidated operating results and
financial condition. No stock-based compensation cost is currently reflected in
net loss for employee option grants as all options granted had an exercise price
equal to or exceeding market value of the underlying common stock on the date of
grant.
RECENT ACCOUNTING PRONOUNCEMENTS
In December 2004, the FASB issued FASB Statement No. 123R, "Share-Based Payment,
an Amendment of FASB Statement No. 123" ("FAS No. 123R"). FAS No. 123R requires
companies to recognize, in the statement of operations, the grant-date fair
value of stock options and other equity-based compensation issued to employees.
FAS No. 123R is effective for the Company on January 1, 2006. We are in process
of evaluating the impact of this pronouncement on our financial position.
In May 2005, FASB issued FASB Statement 154, "Accounting Changes and Error
Corrections -- a replacement of APB Opinion No. 20 and FASB Statement No. 3" ("
FAS 154"). FAS 154 changes the requirements for the accounting for and reporting
of a change in accounting principle. The provisions of FAS 154 require, unless
impracticable, retrospective application to prior periods' financial statements
of (1) all voluntary changes in principles and (2) changes required by a new
accounting pronouncement, if a specific transition is not provided. FAS 154 also
requires that a change in depreciation, amortization, or depletion method for
long-lived, non-financial assets be accounted for as a change in accounting
estimate, which requires prospective application of the new method. FAS 154 is
effective for all accounting changes made in fiscal years beginning after
December 15, 2005.
ITEM 3. CONTROLS AND PROCEDURES
Our Chief Executive Officer and Chief Financial Officer (collectively, the
"Certifying Officers") are responsible for establishing and maintaining
disclosure controls and procedures for us. Based upon such officers' evaluation
of these controls and procedures as of a date as of the end of the period
covered by this Quarterly Report, and subject to the limitations noted
hereinafter, the Certifying Officers have concluded that our disclosure controls
and procedures are effective to ensure that information required to be disclosed
by us in this Quarterly Report is accumulated and communicated to management,
including our principal executive officers as appropriate, to allow timely
decisions regarding required disclosure.
The Certifying Officers have also indicated that there were no significant
changes in our internal controls or other factors that could significantly
affect such controls subsequent to the date of their evaluation, and there were
no corrective actions with regard to significant deficiencies and material
weaknesses.
-22-
ITEM 3. CONTROLS AND PROCEDURES (CONTINUED)
Our management, including each of the Certifying Officers, does not expect that
our disclosure controls or our internal controls will prevent all error and
fraud. A control system, no matter how well conceived and operated, can provide
only reasonable, not absolute, assurance that the objectives of the control
system are met. In addition, the design of a control system must reflect the
fact that there are resource constraints, and the benefits of controls must be
considered relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, within a company have been
detected. These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of simple
error or mistake. Additionally, controls can be circumvented by the individual
acts of some persons, by collusion of two or more people or by management
override of the control. The design of any systems of controls also is based in
part upon certain assumptions about the likelihood of future events, and there
can be no assurance that any design will succeed in achieving its stated goals
under all potential future conditions. Over time, control may become inadequate
because of changes in conditions, or the degree of compliance with the policies
or procedures may deteriorate. Because of these inherent limitations in a
cost-effective control system, misstatements due to error or fraud may occur and
not be detected.
PART II
Item 1 - Legal Proceedings
On March 14, 2005, X-Clearing Corp, a Colorado corporation
("X-Clearing"), our former transfer agent, initiated legal proceedings
against us by filing a complaint and verified motion for replevin and
for temporary order to preserve property in the District Court of the
City and County of Denver, State of Colorado, civil action no. 05 CV
1980 (the "Complaint"). During September 2001, we had entered into an
agreement with X-Clearing Corp. regarding engagement as our transfer
agent, registrar and disbursing agent in connection with our shares of
Common Stock (the "Transfer Agent Agreement"). The Complaint generally
alleges that: (i) we have breached and wrongfully attempted to
terminate the Transfer Agent Agreement; (ii) X-Clearing has a valid and
perfected security interest in our books and records in accordance with
the terms of the Transfer Agent Agreement; and (iii) X-Clearing is
entitled to an order from the District Court replevining and preventing
us from altering, destroying or otherwise interfering with the valid
and perfected security interest and liquidated damages.
On April 5, 2005, we filed an answer to Complaint, counterclaims and
jury demand (the "Answer"). The Answer generally denies that: (i) we
breached and attempted to wrongfully terminate the Transfer Agent
Agreement; (ii) X-Clearing Corp. has a valid and perfected security
interest in our books and records; (iii) X-Clearing is entitled to an
order of replevin and liquidated damages. Our Answer further states
that: (i) X-Clearing Corp. has failed to take reasonable steps to
minimize or mitigate its claimed damages; and (ii) X-Clearing Corp.'s
claims are barred by the statute of frauds, doctrine of laches,
doctrine of accord and satisfaction. Our Answer further counterclaims
that: (i) despite X-Clearing Corp. being paid all administrative fees,
share transfer fees and fees for new issuances, X-Clearing Corp. has
refused to produce and provide us with our stock transfer records,
which has caused us irreparable harm; (ii) X-Clearing Corp. has
continued undertaking stock transfers on our behalf and illegally
issuing fraudulent stock certificates; and (iii) X-Clearing Corp. has
improperly and illegally used our records, which included stock
certificates that X-Clearing Corp. has fraudulently created and issued
to make stock transfers without notification to us.
On April 7, 2005, we filed a stipulated motion for testimony by
telephone and for expedited ruling by court. A hearing was set for
April 12, 2005. X-Clearing Corp.'s replevin action was dismissed by the
District Court. As of the date of this Quarterly Report, we intend to
aggressively pursue all such legal actions and review further legal
remedies against X-Clearing Corp.
The parties through legal counsel are currently in negotiation for
settlement by mutual agreement.
Other than as disclosed above, we are not aware of any legal
proceedings contemplated by any governmental authority or other party
involving us or our subsidiaries or our properties. None of our
directors, officers or affiliates are: (i) a party adverse to us in any
legal proceedings; or (ii) has an adverse interest to us in any legal
proceedings. We are not aware of any other legal proceedings pending or
that have been threatened against us, our subsidiaries or our
properties.
-23-
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds.
On June 28, 2005, the holder of the related party notes partially
exercised the conversion feature. Accordingly, we issued 400,000 shares
at the conversion price of $.125 per share and 400,000 warrants to
purchase common stock of the Company at $.25 per share (see note 2 to
the unaudited consolidated financial statements included elsewhere in
this filing) for the conversion of principal balance of $50,000. We
also issued 35,770 shares of common stock to settle $4,471 in interest
due on these loans.
On June 28, 2005, we issued 300,000 shares of common stock at $.11 per
share, the fair market value on the date of grant for settlement of
$33,000 of this debt.
The recipients are sophisticated investors who have such knowledge and
experience in financial, investment and business matters that they are
capable of evaluating the merits and risks of the prospective
investment in our securities. The recipients are accredited investors.
The issuance was exempt from registration under the Securities Act in
reliance on an exemption provided by Section 4(2) of that act.
Item 3 - Defaults Upon Senior Securities
None.
Item 4 - Submissions of Matters to a Vote of Security Holders
None
Item 5. Other Information
None
Item 6. Exhibits
31.1 Rule 13a - 14(a)/15d-14(a) Certification of the Chief Executive Officer
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Rule 13a - 14(a)/15d-14(a) Certification of the Chief Financial Officer
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer Certification pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
32.2 Certification of Chief Financial Officer Certification pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
TRANSAX INTERNATIONAL LIMITED
Date: August 18, 2005 By: /s/ Stephen Walters
-------------------
Stephen Walters
Chief Executive Officer
Date: August 18, 2005 By: /s/Adam Wasserman
-----------------
Adam Wasserman
Principal Financial and
Accounting Officer
-24-